BIOVICES IPR HOLDING Aps holds a unique set of intellectual property rights that is being injected into operations in daughter companies. The first company will be NanoWisa for treatment of antibiotic resistant bacteria with a patented nanotechnology. We provide expert oversight of the entire process from discovery to exit.
Our discovery team validates all projects according to best engineering and scientific practices and ensures proof of principle and proof of concept which are evaluated by our expert advisory board. Hereto, we ensure that the IPR protection is in place.